| Literature DB >> 26645277 |
Pablo Emiliano Canton1, Angeles Cancino-Rodezno2, Sarjeet S Gill3, Mario Soberón1, Alejandra Bravo4.
Abstract
BACKGROUND: Although much is known about the mechanism of action of Bacillus thuringiensis Cry toxins, the target tissue cellular responses to toxin activity is less understood. Previous transcriptomic studies indicated that significant changes in gene expression occurred during intoxication. However, most of these studies were done in organisms without a sequenced and annotated reference genome. A reference genome and transcriptome is available for the mosquito Aedes aegypti, and its importance as a disease vector has positioned its biological control as a primary health concern. Through RNA sequencing we sought to determine the transcriptional changes observed during intoxication by Cry11Aa in A. aegypti and to analyze possible defense and recovery mechanisms engaged after toxin ingestion.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26645277 PMCID: PMC4673840 DOI: 10.1186/s12864-015-2240-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Number of genes reported in differential expression analysis by DESeq2 (P-adj < 0.05) and EdgeR (FDR < 0.05)
| Condition | EdgeR | DESeq2 | Common | Only EdgeR | Only DESeq2 | |
|---|---|---|---|---|---|---|
| 3 h | all | 10 | 5 | 4 | 6 | 1 |
| Up regulated | 3 | 1 | 1 | 2 | 0 | |
| Down regulated | 7 | 4 | 3 | 4 | 1 | |
| 6 h | all | 33 | 340 | 27 | 6 | 313 |
| Up regulated | 24 | 245 | 23 | 1 | 222 | |
| Down regulated | 9 | 95 | 4 | 5 | 91 | |
| 9 h | all | 151 | 458 | 145 | 6 | 313 |
| Up regulated | 105 | 273 | 104 | 1 | 169 | |
| Down regulated | 46 | 185 | 41 | 5 | 144 | |
| 12 h | all | 1059 | 1980 | 1038 | 21 | 942 |
| Up regulated | 623 | 1123 | 613 | 10 | 510 | |
| Down regulated | 436 | 857 | 425 | 11 | 432 | |
| all | 39 | 16 | 13 | 26 | 3 | |
| 12 h no toxin | Up regulated | 20 | 7 | 4 | 16 | 3 |
| Down regulated | 19 | 9 | 9 | 10 | 0 |
Fig. 1Enrichment analysis for biological process GO terms. For each experimental condition, terms reported as enriched by TopGO on differentially expressed genes (as described in Methods) are colored green if present in down regulated genes, red if found in up regulated genes, and purple if found in both sets of genes. Some related GO terms are shown as one for simplicity
Fig. 2Clustering of differentially expressed genes by expression profile. Log2 fold expression profiles from 0 to 12 h of Cry11Aa exposure for all genes determined as differentially expressed in at least one experimental condition and clustered using DEseq2 and Cluster 3.0 as described in Methods. We considered strong response when difference between maximal and minimal expression values are over 2 fold and moderate response when difference between maximal and minimal expression values are equal or lower than 2 fold. Cluster a, represents genes with moderate down regulation; cluster b, strong down regulation; cluster c, moderate up regulation and cluster d, strong up regulation
TopGO enrichment of biological process terms in differentially expressed gene clusters
| Cluster | GO.ID | Term | Annotated | Significant | Expected | ClassicFisher |
|---|---|---|---|---|---|---|
| A. Moderate down regulated | GO:0055114 | oxidation-reduction process | 769 | 75 | 29.4 | 2.10E-13 |
| GO:0008272 | sulfate transport | 10 | 5 | 0.38 | 1.70E-05 | |
| GO:0006081 | cellular aldehyde metabolic process | 9 | 3 | 0.34 | 0.0039 | |
| GO:0032787 | monocarboxylic acid metabolic process | 70 | 8 | 2.68 | 0.0067 | |
| GO:0006749 | glutathione metabolic process | 14 | 3 | 0.54 | 0.0147 | |
| GO:0005978 | glycogen biosynthetic process | 6 | 2 | 0.23 | 0.0197 | |
| GO:1901700 | response to oxygen-containing compound | 6 | 2 | 0.23 | 0.0197 | |
| GO:0044270 | cellular nitrogen compound catabolic process | 385 | 17 | 14.72 | 0.0235 | |
| GO:0046700 | heterocycle catabolic process | 386 | 17 | 14.76 | 0.0264 | |
| GO:0006099 | tricarboxylic acid cycle | 18 | 3 | 0.69 | 0.0295 | |
| GO:0044262 | cellular carbohydrate metabolic process | 41 | 6 | 1.57 | 0.0318 | |
| GO:1901361 | organic cyclic compound catabolic process | 388 | 17 | 14.83 | 0.0326 | |
| GO:0006730 | one-carbon metabolic process | 8 | 2 | 0.31 | 0.035 | |
| GO:1901292 | nucleoside phosphate catabolic process | 357 | 13 | 13.65 | 0.0511 | |
| GO:0055085 | transmembrane transport | 576 | 34 | 22.02 | 0.0619 | |
| GO:0043648 | dicarboxylic acid metabolic process | 11 | 2 | 0.42 | 0.0638 | |
| GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway | 11 | 2 | 0.42 | 0.0638 | |
| GO:0044106 | cellular amine metabolic process | 20 | 3 | 0.76 | 0.0743 | |
| GO:0006979 | response to oxidative stress | 28 | 3 | 1.07 | 0.0897 | |
| B. Strong down regulated | GO:0006952 | defense response | 14 | 2 | 0.01 | 0.0021 |
| GO:1902476 | chloride transmembrane transport | 6 | 1 | 0 | 0.0034 | |
| GO:0042742 | defense response to bacterium | 9 | 1 | 0.01 | 0.0051 | |
| C. Moderate up regulated | GO:0071702 | organic substance transport | 266 | 27 | 10.92 | 2.10E-05 |
| GO:0008610 | lipid biosynthetic process | 103 | 13 | 4.23 | 0.00025 | |
| GO:0016192 | vesicle-mediated transport | 114 | 15 | 4.68 | 0.00091 | |
| GO:0043623 | cellular protein complex assembly | 32 | 7 | 1.31 | 0.00103 | |
| GO:0042398 | cellular modified amino acid biosynthetic process | 20 | 5 | 0.82 | 0.00105 | |
| GO:0007229 | integrin-mediated signaling pathway | 8 | 3 | 0.33 | 0.00329 | |
| GO:0006195 | purine nucleotide catabolic process | 341 | 24 | 14 | 0.00404 | |
| GO:0006955 | immune response | 17 | 4 | 0.7 | 0.00433 | |
| GO:0042742 | defense response to bacterium | 9 | 3 | 0.37 | 0.00478 | |
| GO:0032940 | secretion by cell | 18 | 4 | 0.74 | 0.00539 | |
| GO:0009207 | purine ribonucleoside triphosphate catabolic process | 340 | 24 | 13.96 | 0.00684 | |
| GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 11 | 3 | 0.45 | 0.00884 | |
| GO:0030029 | actin filament-based process | 35 | 6 | 1.44 | 0.00941 | |
| GO:0010466 | negative regulation of peptidase activity | 24 | 4 | 0.99 | 0.01544 | |
| GO:0006108 | malate metabolic process | 5 | 2 | 0.21 | 0.01547 | |
| GO:0007267 | cell-cell signaling | 14 | 3 | 0.57 | 0.0178 | |
| GO:0034613 | cellular protein localization | 136 | 11 | 5.58 | 0.01829 | |
| GO:0007264 | small GTPase mediated signal transduction | 189 | 12 | 7.76 | 0.02202 | |
| GO:0006470 | protein dephosphorylation | 54 | 6 | 2.22 | 0.02244 | |
| GO:0019751 | polyol metabolic process | 6 | 2 | 0.25 | 0.02258 | |
| GO:1901617 | organic hydroxy compound biosynthetic process | 6 | 2 | 0.25 | 0.02258 | |
| GO:0016051 | carbohydrate biosynthetic process | 26 | 4 | 1.07 | 0.04051 | |
| GO:0006457 | protein folding | 80 | 7 | 3.28 | 0.04524 | |
| GO:0007017 | microtubule-based process | 81 | 7 | 3.33 | 0.04786 | |
| GO:0046130 | purine ribonucleoside catabolic process | 340 | 24 | 13.96 | 0.04798 | |
| GO:0048285 | organelle fission | 34 | 4 | 1.4 | 0.04903 | |
| GO:0000165 | MAPK cascade | 9 | 2 | 0.37 | 0.04995 | |
| GO:0006270 | DNA replication initiation | 9 | 2 | 0.37 | 0.04995 | |
| GO:0033014 | tetrapyrrole biosynthetic process | 10 | 2 | 0.41 | 0.06079 | |
| GO:0046939 | nucleotide phosphorylation | 11 | 2 | 0.45 | 0.07233 | |
| GO:0016998 | cell wall macromolecule catabolic process | 11 | 2 | 0.45 | 0.07233 | |
| GO:0000902 | cell morphogenesis | 11 | 2 | 0.45 | 0.07233 | |
| GO:0044262 | cellular carbohydrate metabolic process | 41 | 4 | 1.68 | 0.08597 | |
| GO:0006879 | cellular iron ion homeostasis | 13 | 2 | 0.53 | 0.09725 | |
| GO:0006826 | iron ion transport | 13 | 2 | 0.53 | 0.09725 | |
| GO:0046854 | phosphatidylinositol phosphorylation | 13 | 2 | 0.53 | 0.09725 | |
| D. Strong up regulated | GO:0016042 | lipid catabolic process | 51 | 2 | 0.11 | 0.005 |
| GO:0034314 | Arp2/3 complex-mediated actin nucleation | 7 | 1 | 0.01 | 0.015 | |
| GO:0070588 | calcium ion transmembrane transport | 17 | 1 | 0.04 | 0.035 | |
| GO:0032319 | regulation of Rho GTPase activity | 24 | 1 | 0.05 | 0.05 |
Fig. 3Molecular functions of genes differentially expressed. For each experimental condition, genes were categorized into different categories as reported by TopGO and enrichment on differentially expressed genes (as described in Methods) are colored green indicating down regulated genes, red indicating up regulated genes, and purple if found in both sets of genes
Representative Interpro domains identified on differential expressed genes without biological process GO annotation
| Condition | InteproID | Percentile | Description |
|---|---|---|---|
| 6 h down regulated | IPR007588 | 1 | Zync finger, FLYWCH-type |
| 6 h up regulated | IPR002018 | 0.94 | Carboxylesterase, typeB |
| IPR029058 | 1 | Alpha/Beta hydrolase fold | |
| 9 h down regulated | IPR007087 | 0.9 | Zync finger, C2H2 |
| 9 h up regulated | IPR013126 | 0.966 | Heat shock protein 70 family |
| IPR029058 | 0.955 | Alpha/Beta hydrolase fold | |
| IPR002018 | 0.944 | Carboxylesterase, typeB | |
| IPR013783 | 0.933 | Immunoglobulin-like fold | |
| 12 h down regulated | IPR007087 | 0.996 | Zync finger, C2H2 |
| IPR011009 | 0.977 | Protein kinase-like domain | |
| IPR013026 | 0.936 | Tetratricopeptide repeat-containing domain | |
| IPR013525 | 0.936 | ABC-2 type transporter | |
| 12 h up regulated | IPR029058 | 1 | Alpha/Beta hydrolase fold |
| IPR008978 | 0.997 | HSP20-like chaperone | |
| IPR027417 | 0.988 | P-loop containing nucleoside triphoshpate hydrolase | |
| IPR013126 | 0.969 | Heat shock protein 70 family | |
| IPR002048 | 0.969 | EF-hand domain | |
| IPR002018 | 0.958 | Carboxylesterase, typeB | |
| IPR001849 | 0.947 | Pleckstrin homology domain | |
| IPR015880 | 0.947 | Zync finger C2H2-like | |
| IPR002110 | 0.925 | Ankyrin repeat | |
| IPR001452 | 0.925 | SH3 domain | |
| IPR008985 | 0.925 | Concanavalin A-like lectin/glucanases superfamily | |
| IPR018502 | 0.925 | Annexin repeat |
Homologs to differentially expressed genes without biological process GO annotation found by pBLAST analysis
| Condition | Gene ID | Coverage |
| Identity | Homolog ID | Protein | Species |
|---|---|---|---|---|---|---|---|
| 9 h Down regulated | AAEL013895 | 90 % | 1e-32 | 53 % | XP_001868961.1 | 14.5 kDa salivary protein | Cq |
| AAEL009985 | 94 % | 2e-59 | 65 % | XP_001868961.1 | 14.5 kDa salivary protein | Cq | |
| AAEL000777 | 83 % | 3e-15 | 60 % | ABU80079.1 | CEC-A | Ag | |
| AAEL004522 | 98 % | 8e-29 | 65 % | ACA05605.1 | gambicin | Am | |
| 9 h up regulated | AAEL007206 | 92 % | 2e-22 | 48 % | XP_004526025.1 | arhytmically expressed gene 5 protein-like | Cc |
| AAEL000811 | 91 % | 1e-127 | 48 % | ETN67412.1 | methusalah | Ad | |
| AAEL002963 | 32 % | 5e-09 | 57 % | XP_008549507.1 | aras guanine nucleotide exchange factor L isoform X8 | Md | |
| 12 h Down regulated | AAEL006228 | 98 % | 9e-102 | 45 % | XP_001846856.1 | PPARgamma constitutive conactivator 1 | Cq |
| AAEL012622 | 98 % | 5e-108 | 68 % | XP_001862944.1 | ADAM metalloprotease | Cq | |
| AAEL007780 | 96 % | 2e-107 | 57 % | AAV90698.1 | putative salivary secreted protein 275 | Aa | |
| AAEL009985 | 94 % | 2e-59 | 65 % | XP_001868961.1 | 14.5 kDa salivary protein | Cq | |
| AAEL006346 | 81 % | 5e-62 | 55 % | XP_005177200.1 | aBAG family molecular chaperone regulator 2-like isoform X1 | Mud | |
| AAEL003594 | 98 % | 1e-169 | 61 % | XP_001862361.1 | microtubule binding protein D-CLIP-190 | Cq | |
| AAEL013356 | 30 % | 8e-62 | 62 % | XP_003401795.1 | aeukaryotic initiation factor 4A-like isoform 2 | Bi | |
| 12 h Up regulated | AAEL006493 | 98 % | 7e-11 | 49 % | AAV90653.1 | putative salivary secreted peptide | Aa |
| AAEL005874 | 100 % | 4e-63 | 73 % | XP_003707525.1 | aE3 ubiquitin-protein ligase AMFR-like | Mr | |
| AAEL006493 | 98 % | 7e-11 | 49 % | AAV90653.1 | putative salivary secreted peptide | Aa | |
| AAEL013220 | 75 % | 3e-62 | 72 % | NP_648500.1 | crimpled | Dm | |
| AAEL011867 | 92 % | 0 | 40 % | XP_003395464.1 | amuscle M-line assembly protein unc-89 isoform X3 | Apm | |
| AAEL014310 | 86 % | 8e-34 | 79 % | NP_648366.2 | calcium-independent phospholipase A2 VIA, isoform B | Dm | |
| AAEL007206 | 92 % | 2e-22 | 48 % | XP_004526025.1 | arhythmically expressed gene 5 protein | Cc | |
| AAEL001576 | 94 % | 1e-31 | 83 % | ETN61409.1 | cysteine string protein | Ad | |
| AAEL003567 | 99 % | 6e-43 | 49 % | AAV90653.1 | putative salivary secreted peptide | Aa | |
| AAEL002578 | 97 % | 1e-59 | 65 % | NP_649184.1 | snakeskin, isoform A | Dm | |
| AAEL000811 | 91 % | 1e-127 | 48 % | ETN67412.1 | methusalah | Ad | |
| AAEL005428 | 98 % | 2e-32 | 51 % | ABV44740.1 | 13.6 kDa midgut protein | Pp | |
| AAEL002963 | 32 % | 5e-09 | 57 % | XP_008549503.1 | amyb-like protein J isoform X4 | Md |
Aa Aedes albopictus, Ad Anopheles darlingi, Ag Anopheles gambiae, Am Anopheles melas, Apm Apis mellifera, Bi Bombus impatiens, Cc Ceratitis capitata, Cq Culex quinquefasciatus, Dm Drosophila melanogaster, Md Microplitis demolitor, Mud Musca domestica, Mr Megachile roduntata, Pp Phlebotomus papatasi
aindicates protein classified as “PREDICTED”
Fig. 4RNAseq and RT-qPCR correlation. Transcript abundance ratios were determined for each gene by SYBR Green RT-qPCR on a biological replicate of a 12 h Cry11Aa exposure curve, a control curve of non-toxin exposed A. aegypti larvae, or larvae exposed to non-lethal Cry11Aa mutants. Spearman correlation was determined between corresponding RNAseq values and log2 transformed abundance ratios. Strong positive correlations (above 0.5) are colored in white, weak positive correlation (between 0.3 and 0.5) are colored in light gray, and low, negative or no correlation values are colored in dark gray. Genes are indicated to be up regulated or down regulated as determined by RNAseq analysis. The percentage of genes with strong positive correlation between each curve and RNAseq data is shown